BIOTON S.A. (BIO.WA)

Every figure this model derived for BIO.WA, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2022-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 29,578,000 PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities 2022-12-31
cash 9,339,000 CashAndCashEquivalents 2023-01-01
current assets 153,071,000 CurrentAssets 2023-01-01
current liabilities 141,054,000 CurrentLiabilities 2023-01-01
equity 606,060,000 EquityAttributableToOwnersOfParent 2023-01-01
interest expense 16,306,000 FinanceCosts 2022-12-31
ocf 56,082,000 CashFlowsFromUsedInOperatingActivities 2022-12-31
revenue 233,159,000 Revenue 2022-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up BIO.WA on one particular measure came for.

RatioValue
cash operating margin9.12
current ratio1.09
current ratio reported1.09
fcf margin11.37
interest cover1.3
operating margin9.12
owner earnings margin11.37
revenue growth43.01
revenue growth per share43.01
roic2.81
rule of 4052.13
sbc pct revenue0.0

What to be careful about

What this model itself distrusts about BIO.WA's figures. Written by the derivation as it ran, not added afterwards.